Cdk4 Is Indispensable for Postnatal Proliferation of the Anterior Pituitary*

For proper development and tissue homeostasis, cell cycle progression is controlled by multilayered mechanisms. Recent studies using knock-out mice have shown that animals can develop relatively normally with deficiency for each of the G1/S-regulatory proteins, D-type and E-type cyclins, cyclin-dependent kinase 4 (Cdk4), and Cdk2. Although Cdk4-null mice show no embryonic lethality, they exhibit specific endocrine phenotypes, i.e. dwarfism, infertility, and diabetes. Here we have demonstrated that Cdk4 plays an essential non-redundant role in postnatal proliferation of the anterior pituitary. Pituitaries from wild-type and Cdk4-null embryos at embryonic day 17.5 are morphologically indistinguishable with similar numbers of cells expressing a proliferating marker, Ki67, and cells expressing a differentiation marker, growth hormone. In contrast, anterior pituitaries of Cdk4-null mice at postnatal 8 weeks are extremely hypoplastic with markedly decreased numbers of Ki67+ cells, suggesting impaired cell proliferation. Pituitary hyperplasia induced by transgenic expression of human growth hormone-releasing hormone (GHRH) is significantly diminished in the Cdk4+/– genetic background and completely abrogated in the Cdk4–/– background. Small interfering RNA (siRNA)-mediated knockdown of Cdk4 inhibits GHRH-induced proliferation of GH3 somato/lactotroph cells with restored expression of GHRH receptors. Cdk4 siRNA also inhibits estrogen-dependent cell proliferation in GH3 cells and closely related GH4 cells. In contrast, Cdk6 siRNA does not diminish proliferation of these cells. Furthermore, Cdk4 siRNA does not affect GHRH-induced proliferation of mouse embryonic fibroblasts or estrogen-dependent proliferation of mammary carcinoma MCF-7 cells. Taken together, Cdk4 is dispensable for prenatal development of the pituitary or proliferation of other non-endocrine tissues but indispensable specifically for postnatal proliferation of somato/lactotrophs.

[1]  Pierre Dubus,et al.  Mammalian Cells Cycle without the D-Type Cyclin-Dependent Kinases Cdk4 and Cdk6 , 2004, Cell.

[2]  Fang Liu,et al.  Cyclin-dependent kinases regulate the antiproliferative function of Smads , 2004, Nature.

[3]  Douglas A. Melton,et al.  Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation , 2004, Nature.

[4]  C. Sherr,et al.  Principles of Tumor Suppression , 2004, Cell.

[5]  S. Rane,et al.  Characterization of the abnormal pancreatic development, reduced growth and infertility in Cdk4 mutant mice , 2003, Oncogene.

[6]  P. Kaldis,et al.  Cdk2 Knockout Mice Are Viable , 2003, Current Biology.

[7]  Yan Geng,et al.  Cyclin E Ablation in the Mouse , 2003, Cell.

[8]  Pierre Dubus,et al.  Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice , 2003, Nature Genetics.

[9]  M. Barbacid,et al.  Genetic rescue of Cdk4 null mice restores pancreatic β-cell proliferation but not homeostatic cell number , 2003, Oncogene.

[10]  D. Rowitch,et al.  Development of mice expressing a single D-type cyclin. , 2002, Genes & development.

[11]  N. Dyson,et al.  A revised picture of the E2F transcriptional network and RB function. , 2002, Current opinion in cell biology.

[12]  Michael Rosenfeld,et al.  Signaling and transcriptional control of pituitary development. , 2002, Current opinion in genetics & development.

[13]  R. Kineman,et al.  Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis , 2002, Trends in Endocrinology & Metabolism.

[14]  S. Artavanis-Tsakonas,et al.  Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. delle Fave,et al.  p27: a potential main inhibitor of cell proliferation in digestive endocrine tumors but not a marker of benign behavior. , 2001, Human pathology.

[16]  C. Bernard-Kargar,et al.  Endocrine pancreas plasticity under physiological and pathological conditions. , 2001, Diabetes.

[17]  A. Koff,et al.  Cell-cycle inhibitors: three families united by a common cause. , 2000, Gene.

[18]  K. Christov,et al.  p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation , 2000, Oncogene.

[19]  P. Pandolfi,et al.  Targeted Disruption of CDK4 Delays Cell Cycle Entry with Enhanced p27Kip1 Activity , 1999, Molecular and Cellular Biology.

[20]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[21]  M. Barbacid,et al.  Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia , 1999, Nature Genetics.

[22]  S. Elledge,et al.  Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis , 1996, Nature.

[23]  G. Stamp,et al.  Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. , 1995, Genes & development.

[24]  S. Elledge,et al.  Cyclin D1 provides a link between development and oncogenesis in the retina and breast , 1995, Cell.

[25]  A. Bradley,et al.  Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. , 1994, Oncogene.

[26]  S. Elledge,et al.  CDK2 encodes a 33-kDa cyclin A-associated protein kinase and is expressed before CDC2 in the cell cycle. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Pardee.  G1 events and regulation of cell proliferation. , 1989, Science.

[28]  L. Frohman,et al.  Immunohistochemical analysis of human growth hormone-releasing hormone gene expression in transgenic mice. , 1989, Endocrinology.

[29]  P. Nurse,et al.  Complementation used to clone a human homologue of the fission yeast cell cycle control gene cdc2 , 1987, Nature.

[30]  J. Jansson,et al.  Pre- and postnatal developmental changes in hypothalamic content of rat growth hormone-releasing factor. , 1987, Endocrinology.

[31]  R. Hammer,et al.  Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth , 1985, Nature.

[32]  N. Ling,et al.  Growth hormone (GH)-releasing factor does not regulate GH release or GH mRNA levels in GH3 cells. , 1984, Endocrinology.

[33]  R. Evans,et al.  Epidermal growth factor rapidly stimulates prolactin gene transcription , 1982, Nature.

[34]  A. Tashjian,et al.  Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. , 1968, Endocrinology.